tiprankstipranks
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Hong Kong Market
2126
JW (Cayman) Therapeutics Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2126 full AI Analyst Report?

JW (Cayman) Therapeutics Co. Ltd. (2126) Balance Sheet

0 Followers

JW (Cayman) Therapeutics Co. Ltd. Balance Sheet

JW (Cayman) Therapeutics Co. Ltd.'s total assets for Q4 2025 were ¥987.32M, a decrease of -30.44% from the previous quarter. HK:2126 total liabilities were ¥430.82M for the fiscal quarter, a -15.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
¥ 987.32M¥ 1.68B¥ 2.15B¥ 2.79B¥ 3.12B
Total Liabilities
¥ 430.82M¥ 511.20M¥ 462.26M¥ 437.06M¥ 325.75M
Total Equity Gross Minority
¥ 556.50M¥ 1.17B¥ 1.68B¥ 2.35B¥ 2.79B
Other Metrics
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Debt to Assets